• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For March 10, 2023

    3/10/23 10:00:50 AM ET
    $AAPL
    $AKA
    $ALGT
    $ALK
    Computer Manufacturing
    Technology
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $AAPL alert in real time by email

    Upgrades

    Jefferies upgraded the previous rating for Roblox Corp (NYSE:RBLX) from Hold to Buy. In the fourth quarter, Roblox showed an EPS of $0.48, compared to $0.25 from the year-ago quarter. The stock has a 52-week-high of $53.88 and a 52-week-low of $21.65. At the end of the last trading period, Roblox closed at $39.94.

    According to Piper Sandler, the prior rating for Ameresco Inc (NYSE:AMRC) was changed from Neutral to Overweight. In the fourth quarter, Ameresco showed an EPS of $0.35, compared to $0.50 from the year-ago quarter. At the moment, the stock has a 52-week-high of $86.73 and a 52-week-low of $40.73. Ameresco closed at $44.51 at the end of the last trading period.

    Piper Sandler upgraded the previous rating for KeyCorp (NYSE:KEY) from Underweight to Neutral. For the fourth quarter, KeyCorp had an EPS of $0.38, compared to year-ago quarter EPS of $0.64. The stock has a 52-week-high of $24.71 and a 52-week-low of $15.26. At the end of the last trading period, KeyCorp closed at $16.07.

    According to Baird, the prior rating for KeyCorp (NYSE:KEY) was changed from Neutral to Outperform. For the fourth quarter, KeyCorp had an EPS of $0.38, compared to year-ago quarter EPS of $0.64. The stock has a 52-week-high of $24.71 and a 52-week-low of $15.26. At the end of the last trading period, KeyCorp closed at $16.07.

    According to Citigroup, the prior rating for Silk Road Medical Inc (NASDAQ:SILK) was changed from Sell to Neutral. Silk Road Medical earned $0.34 in the fourth quarter, compared to $0.42 in the year-ago quarter. The current stock performance of Silk Road Medical shows a 52-week-high of $58.04 and a 52-week-low of $27.30. Moreover, at the end of the last trading period, the closing price was at $44.57.

    Mizuho upgraded the previous rating for Marathon Petroleum Corp (NYSE:MPC) from Neutral to Buy. In the fourth quarter, Marathon Petroleum showed an EPS of $6.65, compared to $1.30 from the year-ago quarter. The stock has a 52-week-high of $136.46 and a 52-week-low of $73.17. At the end of the last trading period, Marathon Petroleum closed at $128.38.

    Barclays upgraded the previous rating for United Airlines Holdings Inc (NASDAQ:UAL) from Equal-Weight to Overweight. For the fourth quarter, United Airlines Holdings had an EPS of $2.46, compared to year-ago quarter EPS of $1.60. At the moment, the stock has a 52-week-high of $55.04 and a 52-week-low of $31.58. United Airlines Holdings closed at $52.12 at the end of the last trading period.

    Barclays upgraded the previous rating for Alaska Air Group Inc (NYSE:ALK) from Equal-Weight to Overweight. For the fourth quarter, Alaska Air Gr had an EPS of $0.92, compared to year-ago quarter EPS of $0.24. At the moment, the stock has a 52-week-high of $61.55 and a 52-week-low of $38.19. Alaska Air Gr closed at $47.52 at the end of the last trading period.

    According to Piper Sandler, the prior rating for Zimmer Biomet Holdings Inc (NYSE:ZBH) was changed from Neutral to Overweight. In the fourth quarter, Zimmer Biomet Holdings showed an EPS of $1.88, compared to $1.95 from the year-ago quarter. At the moment, the stock has a 52-week-high of $135.05 and a 52-week-low of $100.39. Zimmer Biomet Holdings closed at $122.35 at the end of the last trading period.

    Piper Sandler upgraded the previous rating for Riskified Ltd (NYSE:RSKD) from Neutral to Overweight. Riskified earned $0.03 in the fourth quarter, compared to $0.04 in the year-ago quarter. The stock has a 52-week-high of $6.79 and a 52-week-low of $3.43. At the end of the last trading period, Riskified closed at $5.38.

    See all analyst ratings upgrades.

    Downgrades

    For Fulcrum Therapeutics Inc (NASDAQ:FULC), HC Wainwright & Co. downgraded the previous rating of Buy to Neutral. For the fourth quarter, Fulcrum Therapeutics had an EPS of $0.50, compared to year-ago quarter EPS of $0.58. The stock has a 52-week-high of $24.79 and a 52-week-low of $3.21. At the end of the last trading period, Fulcrum Therapeutics closed at $4.82.

    According to Guggenheim, the prior rating for Allbirds Inc (NASDAQ:BIRD) was changed from Buy to Neutral. Allbirds earned $0.17 in the fourth quarter, compared to $0.09 in the year-ago quarter. At the moment, the stock has a 52-week-high of $6.85 and a 52-week-low of $2.14. Allbirds closed at $2.36 at the end of the last trading period.

    According to LightShed Partners, the prior rating for Apple Inc (NASDAQ:AAPL) was changed from Neutral to Sell. For the first quarter, Apple had an EPS of $1.88, compared to year-ago quarter EPS of $2.10. The current stock performance of Apple shows a 52-week-high of $179.61 and a 52-week-low of $124.17. Moreover, at the end of the last trading period, the closing price was at $150.59.

    Keefe, Bruyette & Woods downgraded the previous rating for First Eagle Alternative Capital BDC Inc (NASDAQ:FCRD) from to Market Perform. In the third quarter, First Eagle Alternative showed an EPS of $0.13, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $4.91 and a 52-week-low of $2.74. First Eagle Alternative closed at $4.54 at the end of the last trading period.

    TD Cowen downgraded the previous rating for Inseego Corp (NASDAQ:INSG) from Outperform to Market Perform. Inseego earned $0.11 in the fourth quarter, compared to $0.08 in the year-ago quarter. At the moment, the stock has a 52-week-high of $4.92 and a 52-week-low of $0.75. Inseego closed at $0.75 at the end of the last trading period.

    Zelman & Assoc downgraded the previous rating for Beacon Roofing Supply Inc (NASDAQ:BECN) from Hold to Sell. For the first quarter, Beacon Roofing Supply had an EPS of $1.40, compared to year-ago quarter EPS of $1.47. At the moment, the stock has a 52-week-high of $68.31 and a 52-week-low of $45.71. Beacon Roofing Supply closed at $64.65 at the end of the last trading period.

    BMO Capital downgraded the previous rating for Stepan Co (NYSE:SCL) from Outperform to Market Perform. For the fourth quarter, Stepan had an EPS of $0.59, compared to year-ago quarter EPS of $0.97. The stock has a 52-week-high of $116.72 and a 52-week-low of $91.64. At the end of the last trading period, Stepan closed at $98.60.

    According to JP Morgan, the prior rating for DocuSign Inc (NASDAQ:DOCU) was changed from Neutral to Underweight. In the fourth quarter, DocuSign showed an EPS of $0.65, compared to $0.48 from the year-ago quarter. At the moment, the stock has a 52-week-high of $113.67 and a 52-week-low of $39.57. DocuSign closed at $64.41 at the end of the last trading period.

    For Southwest Airlines Co (NYSE:LUV), Barclays downgraded the previous rating of Overweight to Equal-Weight. Southwest Airlines earned $0.38 in the fourth quarter, compared to $0.14 in the year-ago quarter. At the moment, the stock has a 52-week-high of $50.10 and a 52-week-low of $30.20. Southwest Airlines closed at $33.08 at the end of the last trading period.

    According to Morgan Stanley, the prior rating for Stride Inc (NYSE:LRN) was changed from Overweight to Equal-Weight. In the second quarter, Stride showed an EPS of $1.19, compared to $1.00 from the year-ago quarter. The stock has a 52-week-high of $47.35 and a 52-week-low of $30.66. At the end of the last trading period, Stride closed at $43.12.

    For SVB Financial Group (NASDAQ:SIVB), Raymond James downgraded the previous rating of Outperform to Market Perform. In the fourth quarter, SVB Finl Gr showed an EPS of $4.62, compared to $6.22 from the year-ago quarter. At the moment, the stock has a 52-week-high of $597.16 and a 52-week-low of $100.00. SVB Finl Gr closed at $106.04 at the end of the last trading period.

    Truist Securities downgraded the previous rating for SVB Financial Group (NASDAQ:SIVB) from Buy to Hold. SVB Finl Gr earned $4.62 in the fourth quarter, compared to $6.22 in the year-ago quarter. The current stock performance of SVB Finl Gr shows a 52-week-high of $597.16 and a 52-week-low of $100.00. Moreover, at the end of the last trading period, the closing price was at $106.04.

    According to UBS, the prior rating for Caterpillar Inc (NYSE:CAT) was changed from Neutral to Sell. Caterpillar earned $3.86 in the fourth quarter, compared to $2.69 in the year-ago quarter. At the moment, the stock has a 52-week-high of $266.04 and a 52-week-low of $160.60. Caterpillar closed at $240.96 at the end of the last trading period.

    Wolfe Research downgraded the previous rating for SVB Financial Group (NASDAQ:SIVB) from Outperform to Peer Perform. SVB Finl Gr earned $4.62 in the fourth quarter, compared to $6.22 in the year-ago quarter. At the moment, the stock has a 52-week-high of $597.16 and a 52-week-low of $100.00. SVB Finl Gr closed at $106.04 at the end of the last trading period.

    According to Piper Sandler, the prior rating for a.k.a. Brands Holding Corp (NYSE:AKA) was changed from Overweight to Neutral. In the fourth quarter, a.k.a. Brands Holding showed an EPS of $0.03, compared to $0.03 from the year-ago quarter. The stock has a 52-week-high of $4.92 and a 52-week-low of $1.12. At the end of the last trading period, a.k.a. Brands Holding closed at $1.33.

    Jefferies downgraded the previous rating for BioXcel Therapeutics Inc (NASDAQ:BTAI) from Buy to Hold. In the fourth quarter, BioXcel Therapeutics showed an EPS of $1.95, compared to $0.93 from the year-ago quarter. At the moment, the stock has a 52-week-high of $34.12 and a 52-week-low of $8.79. BioXcel Therapeutics closed at $24.56 at the end of the last trading period.

    According to Credit Suisse, the prior rating for Fulcrum Therapeutics Inc (NASDAQ:FULC) was changed from Outperform to Neutral. In the fourth quarter, Fulcrum Therapeutics showed an EPS of $0.50, compared to $0.58 from the year-ago quarter. The current stock performance of Fulcrum Therapeutics shows a 52-week-high of $24.79 and a 52-week-low of $3.21. Moreover, at the end of the last trading period, the closing price was at $4.82.

    For Allbirds Inc (NASDAQ:BIRD), Baird downgraded the previous rating of Outperform to Neutral. For the fourth quarter, Allbirds had an EPS of $0.17, compared to year-ago quarter EPS of $0.09. The current stock performance of Allbirds shows a 52-week-high of $6.85 and a 52-week-low of $2.14. Moreover, at the end of the last trading period, the closing price was at $2.36.

    According to Barclays, the prior rating for Allegiant Travel Co (NASDAQ:ALGT) was changed from Overweight to Equal-Weight. For the fourth quarter, Allegiant Travel had an EPS of $3.17, compared to year-ago quarter EPS of $1.18. At the moment, the stock has a 52-week-high of $176.56 and a 52-week-low of $62.94. Allegiant Travel closed at $100.77 at the end of the last trading period.

    For Allbirds Inc (NASDAQ:BIRD), Telsey Advisory Group downgraded the previous rating of Outperform to Market Perform. For the fourth quarter, Allbirds had an EPS of $0.17, compared to year-ago quarter EPS of $0.09. The stock has a 52-week-high of $6.85 and a 52-week-low of $2.14. At the end of the last trading period, Allbirds closed at $2.36.

    For a.k.a. Brands Holding Corp (NYSE:AKA), Telsey Advisory Group downgraded the previous rating of Outperform to Market Perform. a.k.a. Brands Holding earned $0.03 in the fourth quarter, compared to $0.03 in the year-ago quarter. The stock has a 52-week-high of $4.92 and a 52-week-low of $1.12. At the end of the last trading period, a.k.a. Brands Holding closed at $1.33.

    See all analyst ratings downgrades.

    Initiations

    Maxim Group initiated coverage on Aprea Therapeutics Inc (NASDAQ:APRE) with a Buy rating. The price target for Aprea Therapeutics is set to $16.00. In the third quarter, Aprea Therapeutics showed an EPS of $2.40, compared to $9.00 from the year-ago quarter. The stock has a 52-week-high of $9.90 and a 52-week-low of $0.30. At the end of the last trading period, Aprea Therapeutics closed at $5.08.

    TD Cowen initiated coverage on Vertex Energy Inc (NASDAQ:VTNR) with a Market Perform rating. The price target for Vertex Energy is set to $8.00. For the fourth quarter, Vertex Energy had an EPS of $0.56, compared to year-ago quarter EPS of $0.15. At the moment, the stock has a 52-week-high of $18.10 and a 52-week-low of $5.42. Vertex Energy closed at $9.36 at the end of the last trading period.

    With a Buy rating, Loop Capital initiated coverage on Cross Country Healthcare Inc (NASDAQ:CCRN). The price target seems to have been set at $30.00 for Cross Country Healthcare. For the fourth quarter, Cross Country Healthcare had an EPS of $1.09, compared to year-ago quarter EPS of $1.40. The stock has a 52-week-high of $40.12 and a 52-week-low of $15.26. At the end of the last trading period, Cross Country Healthcare closed at $25.36.

    UBS initiated coverage on McCormick & Co Inc (NYSE:MKC) with a Sell rating. The price target for McCormick & Co is set to $71.00. McCormick & Co earned $0.73 in the fourth quarter, compared to $0.84 in the year-ago quarter. At the moment, the stock has a 52-week-high of $105.19 and a 52-week-low of $71.19. McCormick & Co closed at $72.00 at the end of the last trading period.

    With a Neutral rating, Janney Montgomery Scott initiated coverage on Farmers National Banc Corp (NASDAQ:FMNB). The price target seems to have been set at $14.00 for Farmers National Banc. Farmers National Banc earned $0.42 in the fourth quarter, compared to $0.50 in the year-ago quarter. The current stock performance of Farmers National Banc shows a 52-week-high of $17.75 and a 52-week-low of $12.41. Moreover, at the end of the last trading period, the closing price was at $13.13.

    JonesTrading initiated coverage on Omega Therapeutics Inc (NASDAQ:OMGA) with a Buy rating. The price target for Omega Therapeutics is set to $11.00. In the fourth quarter, Omega Therapeutics showed an EPS of $0.64, compared to $0.44 from the year-ago quarter. At the moment, the stock has a 52-week-high of $11.98 and a 52-week-low of $1.98. Omega Therapeutics closed at $6.98 at the end of the last trading period.

    With a Neutral rating, Citigroup initiated coverage on Sunrun Inc (NASDAQ:RUN). The price target seems to have been set at $27.00 for Sunrun. Sunrun earned $0.29 in the fourth quarter, compared to $0.19 in the year-ago quarter. The stock has a 52-week-high of $39.13 and a 52-week-low of $16.80. At the end of the last trading period, Sunrun closed at $23.64.

    Citigroup initiated coverage on SunPower Corp (NASDAQ:SPWR) with a Neutral rating. The price target for SunPower is set to $16.50. SunPower earned $0.15 in the fourth quarter, compared to $0.07 in the year-ago quarter. The current stock performance of SunPower shows a 52-week-high of $28.42 and a 52-week-low of $12.78. Moreover, at the end of the last trading period, the closing price was at $15.44.

    Citigroup initiated coverage on Shoals Technologies Group Inc (NASDAQ:SHLS) with a Buy rating. The price target for Shoals Technologies Gr is set to $34.00. In the fourth quarter, Shoals Technologies Gr showed an EPS of $0.15, compared to $0.01 from the year-ago quarter. The stock has a 52-week-high of $32.43 and a 52-week-low of $9.58. At the end of the last trading period, Shoals Technologies Gr closed at $23.20.

    With a Buy rating, Roth MKM initiated coverage on Chewy Inc (NYSE:CHWY). The price target seems to have been set at $52.00 for Chewy. Chewy earned $0.01 in the third quarter, compared to $0.08 in the year-ago quarter. At the moment, the stock has a 52-week-high of $52.88 and a 52-week-low of $22.22. Chewy closed at $39.88 at the end of the last trading period.

    With a Neutral rating, Citigroup initiated coverage on Array Technologies Inc (NASDAQ:ARRY). The price target seems to have been set at $24.00 for Array Technologies. For the third quarter, Array Technologies had an EPS of $0.18, compared to year-ago quarter EPS of $0.07. At the moment, the stock has a 52-week-high of $24.59 and a 52-week-low of $5.45. Array Technologies closed at $20.67 at the end of the last trading period.

    Roth MKM initiated coverage on Intuitive Machines Inc (NASDAQ:LUNR) with a Buy rating. The price target for Intuitive Machines is set to $20.00. The current stock performance of Intuitive Machines shows a 52-week-high of $136.00 and a 52-week-low of $8.55. Moreover, at the end of the last trading period, the closing price was at $16.19.

    With an Outperform rating, RBC Capital initiated coverage on Privia Health Group Inc (NASDAQ:PRVA). The price target seems to have been set at $36.00 for Privia Health Gr. For the fourth quarter, Privia Health Gr had an EPS of $0.13, compared to year-ago quarter EPS of $0.06. At the moment, the stock has a 52-week-high of $44.64 and a 52-week-low of $17.99. Privia Health Gr closed at $27.72 at the end of the last trading period.

    Oppenheimer initiated coverage on Pool Corp (NASDAQ:POOL) with an Outperform rating. The price target for Pool is set to $408.00. For the fourth quarter, Pool had an EPS of $1.82, compared to year-ago quarter EPS of $2.63. At the moment, the stock has a 52-week-high of $488.75 and a 52-week-low of $278.10. Pool closed at $349.04 at the end of the last trading period.

    With an Outperform rating, Oppenheimer initiated coverage on Voyager Therapeutics Inc (NASDAQ:VYGR). The price target seems to have been set at $14.00 for Voyager Therapeutics. For the fourth quarter, Voyager Therapeutics had an EPS of $0.61, compared to year-ago quarter EPS of $0.15. At the moment, the stock has a 52-week-high of $10.81 and a 52-week-low of $4.61. Voyager Therapeutics closed at $7.91 at the end of the last trading period.

    See all analyst ratings initiations.

    Get the next $AAPL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAPL
    $AKA
    $ALGT
    $ALK

    CompanyDatePrice TargetRatingAnalyst
    Apple Inc.
    $AAPL
    2/10/2026$325.00 → $340.00Outperform
    Bernstein
    Roblox Corporation
    $RBLX
    2/9/2026$84.00Neutral → Buy
    Roth Capital
    Roblox Corporation
    $RBLX
    2/6/2026$159.00 → $105.00Buy
    Needham
    Allbirds Inc.
    $BIRD
    2/4/2026Buy → Hold
    Maxim Group
    Marathon Petroleum Corporation
    $MPC
    2/4/2026$183.00 → $198.00Buy
    TD Cowen
    Cross Country Healthcare Inc.
    $CCRN
    2/3/2026$11.00Neutral
    Wedbush
    Apple Inc.
    $AAPL
    1/30/2026$315.00 → $325.00Overweight
    Analyst
    Apple Inc.
    $AAPL
    1/30/2026$230.00 → $239.00Underweight
    Barclays
    More analyst ratings

    $AAPL
    $AKA
    $ALGT
    $ALK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President/CEO Gilad Oren bought $25,009 worth of shares (28,100 units at $0.89), increasing direct ownership by 8% to 373,720 units (SEC Form 4)

    4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)

    2/2/26 4:08:08 PM ET
    $APRE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SrVP/CFO/Prin Fin & Acct Ofcr Hamill John P. bought $5,073 worth of shares (5,700 units at $0.89), increasing direct ownership by 21% to 33,433 units (SEC Form 4)

    4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)

    2/2/26 4:05:34 PM ET
    $APRE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Duey Marc bought $25,000 worth of shares (21,459 units at $1.17), increasing direct ownership by 9% to 256,155 units (SEC Form 4)

    4 - Aprea Therapeutics, Inc. (0001781983) (Issuer)

    12/11/25 8:31:55 AM ET
    $APRE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAPL
    $AKA
    $ALGT
    $ALK
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 17, 2024 - FDA Roundup: September 17, 2024

    For Immediate Release: September 17, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a draft guidance, “Integrating Randomized Controlled Trials for Drug and Biological Products into Routine Clinical Practice,” which, when finalized, will support the conduct of randomized controlled trials with streamlined protocols a

    9/17/24 2:34:22 PM ET
    $AAPL
    Computer Manufacturing
    Technology

    September 12, 2024 - FDA Authorizes First Over-the-Counter Hearing Aid Software

    For Immediate Release: September 12, 2024 Today, the U.S. Food and Drug Administration authorized the first over-the-counter (OTC) hearing aid software device, Hearing Aid Feature, intended to be used with compatible versions of the Apple AirPods Pro headphones. Once installed and customized to the user’s hearing needs, the Hearing Aid Feature enables compatible versions of the AirPods Pro to serve as an OTC hea

    9/12/24 10:58:17 AM ET
    $AAPL
    Computer Manufacturing
    Technology

    December 14, 2023 - FDA Warns Nine Manufacturers, Distributors of Unapproved Antimicrobials for Animals

    For Immediate Release: December 14, 2023 Today, the U.S. Food and Drug Administration is announcing the issuance of nine warning letters to manufacturers and distributors of unapproved and misbranded antimicrobial animal drugs for violations of federal law. The agency is concerned because these products contain antimicrobials that are important in human medicine and using them without medical oversight contribut

    12/14/23 9:00:20 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AAPL
    $AKA
    $ALGT
    $ALK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Bernstein reiterated coverage on Apple with a new price target

    Bernstein reiterated coverage of Apple with a rating of Outperform and set a new price target of $340.00 from $325.00 previously

    2/10/26 7:51:49 AM ET
    $AAPL
    Computer Manufacturing
    Technology

    Roblox upgraded by Roth Capital with a new price target

    Roth Capital upgraded Roblox from Neutral to Buy and set a new price target of $84.00

    2/9/26 6:58:32 AM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    Needham reiterated coverage on Roblox with a new price target

    Needham reiterated coverage of Roblox with a rating of Buy and set a new price target of $105.00 from $159.00 previously

    2/6/26 8:28:08 AM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    $AAPL
    $AKA
    $ALGT
    $ALK
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Allegiant Travel Company

    SCHEDULE 13G - Allegiant Travel CO (0001362468) (Subject)

    2/12/26 9:22:53 AM ET
    $ALGT
    Air Freight/Delivery Services
    Consumer Discretionary

    SEC Form 8-K filed by Voyager Therapeutics Inc.

    8-K - Voyager Therapeutics, Inc. (0001640266) (Filer)

    2/12/26 8:00:38 AM ET
    $VYGR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    BioXcel Therapeutics Inc. filed SEC Form 8-K: Other Events

    8-K - BioXcel Therapeutics, Inc. (0001720893) (Filer)

    2/12/26 7:05:34 AM ET
    $BTAI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAPL
    $AKA
    $ALGT
    $ALK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    Aprea Therapeutics Strengthens Global Patent Portfolio in DNA Damage Response (DDR) Cancer Therapeutics, Paving Way for Pipeline Growth

    New patents granted in 2025 in Australia and Japan bolster global IP coverage for Aprea's WEE1 and ATR programs. Core patent families are expected to provide exclusivity into 2045. Lead WEE1 inhibitor candidate APR-1051 is advancing in Phase 1 trials, with early clinical proof of concept demonstrated and multiple 2026 data readouts anticipated Broad intellectual property protection and ongoing clinical progress position Aprea for long-term value creation DOYLESTOWN, Pa., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (NASDAQ:APRE) ("Aprea" or the "Company"), a clinical-stage biopharmaceutical company developing innovative therapies that exploit cancer-specific vulnerabilitie

    2/12/26 8:30:00 AM ET
    $APRE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BioXcel Therapeutics Completes Market Opportunity Assessment and Advances Commercialization Plans for IGALMI® in the At-Home Setting

    Third party commercial assessment shows larger than expected potential total addressable market for IGALMI® in the at-home setting Strong prescriber interest, patient demand, and positive payer feedback on formulary coverage NEW HAVEN, Conn., Feb. 12, 2026 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (NASDAQ:BTAI), a biopharmaceutical company built on artificial intelligence ("AI") to develop transformative medicines in neuroscience, today announced the completion of an updated market opportunity assessment for IGALMI® for acute agitation associated with bipolar disorders or schizophrenia in the at-home (outpatient) setting, informed by results from the SERENITY At-Home clinical study

    2/12/26 7:00:00 AM ET
    $BTAI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAPL
    $AKA
    $ALGT
    $ALK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Off. & Corp. Sec. Reinstra Mark converted options into 118,110 shares and sold $2,493,475 worth of shares (34,320 units at $72.65), increasing direct ownership by 23% to 454,322 units (SEC Form 4)

    4 - Roblox Corp (0001315098) (Issuer)

    2/11/26 6:57:26 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    Chief People & Systems Officer Chakravarthy Arvind converted options into 114,776 units of Class A Common Stock and sold $6,639,886 worth of Class A Common Stock (95,895 units at $69.24), increasing direct ownership by 33% to 240,570 units (SEC Form 4)

    4 - Roblox Corp (0001315098) (Issuer)

    2/11/26 6:56:36 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    President & CEO Baszucki David converted options into 893,068 shares and sold $19,782,756 worth of shares (272,269 units at $72.66), increasing direct ownership by 326% to 811,373 units (SEC Form 4)

    4 - Roblox Corp (0001315098) (Issuer)

    2/11/26 6:55:53 PM ET
    $RBLX
    Computer Software: Prepackaged Software
    Technology

    $AAPL
    $AKA
    $ALGT
    $ALK
    Leadership Updates

    Live Leadership Updates

    View All

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    Alaska Airlines and Hawaiian Airlines introduce spring menus featuring regional favorites and chef-led dining

    Designed for the season, Alaska Airlines new spring menu celebrates Pacific Northwest partnerships with comforting favorites like Beecher's Mac & Cheese, balanced by fresh, seasonal and plant-forward offeringsHawaiian Airlines is refreshing its domestic First Class dining with new menus by Chef Robynne Maii and Chef Wade Ueoka bringing thoughtfully crafted, island-inspired comfort on flights between Hawai'i and the U.S. ContinentSEATTLE, Feb. 11, 2026 /PRNewswire/ --  Alaska Airlines and Hawaiian Airlines are welcoming spring with the launch of new seasonal menus, bringing fresh flavors, thoughtful sourcing and chef-inspired dishes to guests.

    2/11/26 8:00:00 AM ET
    $ALK
    Air Freight/Delivery Services
    Consumer Discretionary

    'Blue Sky' Reaches New Altitude: JetBlue and United Begin Offering Sales Across Both Airlines

    Starting this week, customers can book Blue Sky itineraries with cash or points and miles directly through JetBlue or United—unlocking broader access and a more seamless booking experience across both airlines. JetBlue (NASDAQ:JBLU) and United Airlines (NASDAQ:UAL) today announced the roll out of the next major customer benefit from their Blue Sky collaboration: beginning this week, travelers can start to purchase eligible itineraries operated by either airline directly on JetBlue.com, United.com and each airline's mobile app. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210620738/en/Photo courtesy of JetBlue and United.

    2/10/26 2:00:00 PM ET
    $JBLU
    $UAL
    Air Freight/Delivery Services
    Consumer Discretionary

    $AAPL
    $AKA
    $ALGT
    $ALK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by KeyCorp

    SC 13D/A - KEYCORP /NEW/ (0000091576) ()

    1/5/94 12:00:00 AM ET
    $KEY
    Major Banks
    Finance

    Amendment: SEC Form SC 13D/A filed by Intuitive Machines Inc.

    SC 13D/A - Intuitive Machines, Inc. (0001844452) (Subject)

    11/20/24 5:01:02 PM ET
    $LUNR
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by Array Technologies Inc.

    SC 13G/A - Array Technologies, Inc. (0001820721) (Subject)

    11/14/24 7:59:57 PM ET
    $ARRY
    Miscellaneous manufacturing industries
    Consumer Discretionary

    $AAPL
    $AKA
    $ALGT
    $ALK
    Financials

    Live finance-specific insights

    View All

    Zimmer Biomet Announces Fourth Quarter and Full-Year 2025 Financial Results

    Fourth quarter net sales of $2.244 billion increased 10.9% on a reported basis, 9.2% on a constant currency1 basis and 5.4% on an organic constant currency1 basisFourth quarter diluted earnings per share were $0.70, a decrease of 41.7%; adjusted1 diluted earnings per share were $2.42, an increase of 4.8%Full-year net sales of $8.232 billion increased 7.2% on a reported basis, 6.4% on a constant currency1 basis and 3.9% on an organic constant currency1 basisFull-year diluted earnings per share were $3.55, a decrease of 19.9%; adjusted1 diluted earnings per share were $8.20, an increase of 2.5%Company provides full-year 2026 financial guidanceWARSAW, Ind., Feb. 10, 2026 /PRNewswire/ -- Zimmer

    2/10/26 6:30:00 AM ET
    $ZBH
    Industrial Specialties
    Health Care

    Pool Corporation Announces Year End and Fourth Quarter 2025 Earnings Release Date and Conference Call

    COVINGTON, La., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Pool Corporation (Nasdaq: POOL) announced today that the Company will release its full year and fourth quarter 2025 earnings results before the market opens on February 19, 2026, and will hold a conference call to discuss the results at 10:00 a.m. Central Time (11:00 a.m. Eastern Time) that same day. The earnings release as well as a live webcast and replay of the conference call will be available on the Company's website at www.poolcorp.com. The conference call can also be accessed by dialing 1-888-348-8936 (domestic) or 1-412-902-4265 (international).   Pool Corporation is the world's largest wholesale distributor of swimming pool and re

    2/5/26 4:05:00 PM ET
    $POOL
    Industrial Specialties
    Consumer Discretionary

    SOUTHWEST AIRLINES DECLARES 188th QUARTERLY DIVIDEND

    DALLAS, Feb. 5, 2026 /PRNewswire/ -- Southwest Airlines Co. (NYSE:LUV) Board of Directors declared a quarterly cash dividend of $.18 per share to Shareholders of record at the close of business on March 12, 2026, on all shares then issued and outstanding. The quarterly dividend will be paid on April 2, 2026. SW-DSR View original content:https://www.prnewswire.com/news-releases/southwest-airlines-declares-188th-quarterly-dividend-302680342.html SOURCE Southwest Airlines Co.

    2/5/26 9:45:00 AM ET
    $LUV
    Air Freight/Delivery Services
    Consumer Discretionary